Application of lipid nanovesicle drug delivery system in cancer immunotherapy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Application of lipid nanovesicle drug delivery system in cancer immunotherapy
Authors
Keywords
-
Journal
JOURNAL OF NANOBIOTECHNOLOGY
Volume 20, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-05-06
DOI
10.1186/s12951-022-01429-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Active targeted Janus nanoparticles enable anti-angiogenic drug combining chemotherapy agent to prevent postoperative hepatocellular carcinoma recurrence
- (2022) Xiu-Ping Zhang et al. BIOMATERIALS
- Combination strategies with PD-1/PD-L1 blockade: current advances and future directions
- (2022) Ming Yi et al. Molecular Cancer
- Augmented EPR effect post IRFA to enhance the therapeutic efficacy of arsenic loaded ZIF-8 nanoparticles on residual HCC progression
- (2022) Xuehua Chen et al. JOURNAL OF NANOBIOTECHNOLOGY
- Recent progress of macrophage vesicle-based drug delivery systems
- (2022) Wen-Jie Xu et al. Drug Delivery and Translational Research
- Self‐Activatable Photo‐Extracellular Vesicle for Synergistic Trimodal Anticancer Therapy
- (2021) Jingjing Ding et al. ADVANCED MATERIALS
- LRP1-mediated pH-sensitive polymersomes facilitate combination therapy of glioblastoma in vitro and in vivo
- (2021) Chen He et al. JOURNAL OF NANOBIOTECHNOLOGY
- Metformin Liposome-Mediated PD-L1 Downregulation for Amplifying the Photodynamic Immunotherapy Efficacy
- (2021) Wei Xiong et al. ACS Applied Materials & Interfaces
- Smart Self‐Assembly Amphiphilic Cyclopeptide‐Dye for Near‐Infrared Window‐II Imaging
- (2021) Hao Chen et al. ADVANCED MATERIALS
- mRNA vaccine for cancer immunotherapy
- (2021) Lei Miao et al. Molecular Cancer
- Cancer statistics for the year 2020: An overview
- (2021) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- The dawn of mRNA vaccines: The COVID-19 case
- (2021) Rein Verbeke et al. JOURNAL OF CONTROLLED RELEASE
- Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy
- (2021) Kai Tang et al. Journal of Hematology & Oncology
- Bioengineered bacteria-derived outer membrane vesicles as a versatile antigen display platform for tumor vaccination via Plug-and-Display technology
- (2021) Keman Cheng et al. Nature Communications
- CAR-T cell therapy: current limitations and potential strategies
- (2021) Robert C. Sterner et al. Blood Cancer Journal
- Chitosan oligosaccharide decorated liposomes combined with TH302 for photodynamic therapy in triple negative breast cancer
- (2021) Yinan Ding et al. JOURNAL OF NANOBIOTECHNOLOGY
- Combination of Chidamide-Mediated Epigenetic Modulation with Immunotherapy: Boosting Tumor Immunogenicity and Response to PD-1/PD-L1 Blockade
- (2021) Kun Tu et al. ACS Applied Materials & Interfaces
- Extracellular vesicles as antigen carriers for novel vaccination avenues
- (2021) Mina Mehanny et al. ADVANCED DRUG DELIVERY REVIEWS
- Gene-engineered exosomes-thermosensitive liposomes hybrid nanovesicles by the blockade of CD47 signal for combined photothermal therapy and cancer immunotherapy
- (2021) Lili Cheng et al. BIOMATERIALS
- Preclinical and Clinical Evidence of Therapeutic Agents for Paclitaxel-Induced Peripheral Neuropathy
- (2021) Takehiro Kawashiri et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Review of 10 years of research on breast cancer patients: Focus on indoleamine 2,3-dioxygenase
- (2021) Kashif Asghar et al. World Journal of Clinical Oncology
- Biomembrane-based nanostructures for cancer targeting and therapy: From synthetic liposomes to natural biomembranes and membrane-vesicles
- (2021) Jing Wang et al. ADVANCED DRUG DELIVERY REVIEWS
- Genetically Programmable Fusion Cellular Vesicles for Cancer Immunotherapy
- (2021) Qian‐Fang Meng et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Cardioprotective effects of melatonin and metformin against doxorubicin-induced cardiotoxicity in rats are through preserving mitochondrial function and dynamics
- (2021) Apiwan Arinno et al. BIOCHEMICAL PHARMACOLOGY
- Outer membrane vesicles (OMVs) enabled bio‐applications: A critical review
- (2021) Yikun Huang et al. BIOTECHNOLOGY AND BIOENGINEERING
- Risk and prognosis of secondary bladder cancer after postoperative radiotherapy for gynecological cancer
- (2021) Li Wen et al. Bosnian Journal of Basic Medical Sciences
- Latest generation estrogen receptor degraders for the treatment of hormone receptor-positive breast cancer
- (2021) Ya-Chi Chen et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Futuristic approach to cancer treatment
- (2021) Deepti Malik et al. GENE
- TLR ligand loaded exosome mediated immunotherapy of established mammary Tumor in mice
- (2021) Muzaffer Yildirim et al. IMMUNOLOGY LETTERS
- Circumferential Stereotactic Body Radiotherapy for Spine Metastasis: The Feasibility, Toxicity and Local Control
- (2021) K. Dibs et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Equipping Cancer Cell Membrane Vesicles with Functional DNA as a Targeted Vaccine for Cancer Immunotherapy
- (2021) Bo Liu et al. NANO LETTERS
- Hybrid Vesicles Based on Autologous Tumor Cell Membrane and Bacterial Outer Membrane To Enhance Innate Immune Response and Personalized Tumor Immunotherapy
- (2021) Mei-Zhen Zou et al. NANO LETTERS
- A cascade targeting strategy based on modified bacterial vesicles for enhancing cancer immunotherapy
- (2021) Yuewen Zhai et al. JOURNAL OF NANOBIOTECHNOLOGY
- Pituitary function following peptide receptor radionuclide therapy for neuroendocrine tumours
- (2021) Marianne S. Elston et al. Cancer Medicine
- D-Peptide-Based Probe for CXCR4-Targeted Molecular Imaging and Radionuclide Therapy
- (2021) Kaat Luyten et al. Pharmaceutics
- A Hybrid Eukaryotic-Prokaryotic Nanoplatform with Photothermal Modality for Enhanced Antitumor Vaccination
- (2020) Qi Chen et al. ADVANCED MATERIALS
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Doxil chemotherapy plus liposomal P5 immunotherapy decreased myeloid-derived suppressor cells in murine model of breast cancer
- (2020) Jamshid Gholizadeh Navashenaq et al. Nanomedicine-Nanotechnology Biology and Medicine
- A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment
- (2020) Vincent J. Munster et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chemotaxis-driven delivery of nano-pathogenoids for complete eradication of tumors post-phototherapy
- (2020) Min Li et al. Nature Communications
- Modified bacterial outer membrane vesicles induce autoantibodies for tumor therapy
- (2020) Weiwei Huang et al. Acta Biomaterialia
- The CD47-SIRPα Immune Checkpoint
- (2020) Meike E.W. Logtenberg et al. IMMUNITY
- Vascular toxic effects of cancer therapies
- (2020) Joerg Herrmann Nature Reviews Cardiology
- Engineered Cell‐Membrane‐Coated Nanoparticles Directly Present Tumor Antigens to Promote Anticancer Immunity
- (2020) Yao Jiang et al. ADVANCED MATERIALS
- Intranasal delivery of cationic liposome-protamine complex mRNA vaccine elicits effective anti-tumor immunity
- (2020) Yaping Mai et al. CELLULAR IMMUNOLOGY
- Liposomal Irinotecan: A Review in Metastatic Pancreatic Adenocarcinoma
- (2020) James E. Frampton DRUGS
- Bacterial outer membrane vesicles as a platform for biomedical applications: An update
- (2020) Min Li et al. JOURNAL OF CONTROLLED RELEASE
- Tumor membrane-based vaccine immunotherapy in combination with anti-CTLA-4 antibody confers protection against immune checkpoint resistant murine triple-negative breast cancer
- (2020) Christopher D. Pack et al. Human Vaccines & Immunotherapeutics
- Bacterial Vesicle-Cancer Cell Hybrid Membrane-Coated Nanoparticles for Tumor Specific Immune Activation and Photothermal Therapy
- (2020) Dongdong Wang et al. ACS Applied Materials & Interfaces
- Biomineralized Bacterial Outer Membrane Vesicles Potentiate Safe and Efficient Tumor Microenvironment Reprogramming for Anticancer Therapy
- (2020) Shuang Qing et al. ADVANCED MATERIALS
- Metabolic modulation via mTOR pathway and anti-angiogenesis remodels tumor microenvironment using PD-L1-targeting codelivery
- (2020) Binfan Chen et al. BIOMATERIALS
- Antitumor immunity by small extracellular vesicles collected from activated dendritic cells through effective induction of cellular and humoral immune responses
- (2020) Akihiro Matsumoto et al. BIOMATERIALS
- Hybrid cellular membrane nanovesicles amplify macrophage immune responses against cancer recurrence and metastasis
- (2020) Lang Rao et al. Nature Communications
- Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment
- (2020) Wenxi Zhou et al. BIOMATERIALS
- Macrophage-based approaches for cancer immunotherapy
- (2020) Nicholas R. Anderson et al. CANCER RESEARCH
- Extracellular vesicles-based drug delivery systems for cancer immunotherapy
- (2020) Tuying Yong et al. JOURNAL OF CONTROLLED RELEASE
- Immune Regulation by Dendritic Cell Extracellular Vesicles in Cancer Immunotherapy and Vaccines
- (2020) Irene Fernández-Delgado et al. Cancers
- Next-generation cell therapies: the emerging role of CAR-NK cells
- (2020) Rafet Basar et al. Blood Advances
- Tumor extracellular vesicles loaded with exogenous Let-7i and miR-142 can modulate both immune response and tumor microenvironment to initiate a powerful anti-tumor response
- (2020) Adeleh Taghi Khani et al. CANCER LETTERS
- Simultaneous blocking of CD47 and PD-L1 increases innate and adaptive cancer immune responses and cytokine release
- (2019) Shu Lian et al. EBioMedicine
- Liposome and immune system interplay: Challenges and potentials
- (2019) Fahimeh Zahednezhad et al. JOURNAL OF CONTROLLED RELEASE
- Engineering Biomimetic Platesomes for pH‐Responsive Drug Delivery and Enhanced Antitumor Activity
- (2019) Guangna Liu et al. ADVANCED MATERIALS
- Organic Semiconducting Pro-nanostimulants for Near-Infrared Photoactivatable Cancer Immunotherapy
- (2019) Jingchao Li et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- High glucose microenvironment accelerates tumor growth via SREBP1-autophagy axis in pancreatic cancer
- (2019) Cancan Zhou et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Cytomembrane nanovaccines show therapeutic effects by mimicking tumor cells and antigen presenting cells
- (2019) Wen-Long Liu et al. Nature Communications
- Adoptive CD8+ T cell therapy against cancer:Challenges and opportunities
- (2019) Xiaotao Jiang et al. CANCER LETTERS
- CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity
- (2019) Wenyan Fu et al. Nature Communications
- Engineering a Rugged Nanoscaffold to Enhance Plug-and-Display Vaccination
- (2018) Theodora Ulli Jordanka Bruun et al. ACS Nano
- PD-1 Blockade Cellular Vesicles for Cancer Immunotherapy
- (2018) Xudong Zhang et al. ADVANCED MATERIALS
- Exosome-Mediated Regulation of Tumor Immunology
- (2018) Naohiro Seo et al. CANCER SCIENCE
- Liposome-based immunity-inducing systems for cancer immunotherapy
- (2018) Eiji Yuba MOLECULAR IMMUNOLOGY
- SIRPα–CD47 Immune Checkpoint Blockade in Anticancer Therapy
- (2018) André Veillette et al. TRENDS IN IMMUNOLOGY
- Toxicity of Cancer Therapies in Older Patients
- (2018) Olivia Le Saux et al. Current Oncology Reports
- Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
- (2018) Gang Chen et al. NATURE
- Cell-Membrane Immunotherapy Based on Natural Killer Cell Membrane Coated Nanoparticles for the Effective Inhibition of Primary and Abscopal Tumor Growth
- (2018) Guanjun Deng et al. ACS Nano
- A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization
- (2018) Miguel F. Sanmamed et al. CELL
- microRNA modified tumor-derived exosomes as novel tools for maturation of dendritic cells
- (2018) Adeleh Taghikhani et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Myeloid‐derived suppressor cells and tumor: Current knowledge and future perspectives
- (2018) Elahe Safari et al. JOURNAL OF CELLULAR PHYSIOLOGY
- ASCO, NCCN, MASCC/ESMO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in adult patients
- (2018) Yasmeen Razvi et al. SUPPORTIVE CARE IN CANCER
- The therapeutic potential of bone marrow mesenchymal stem cells in premature ovarian failure
- (2018) Yantao He et al. Stem Cell Research & Therapy
- Indoleamine 2,3-Dioxygenase and Tolerance: Where Are We Now?
- (2017) Andrew L. Mellor et al. Frontiers in Immunology
- Tumour-bound RNA-laden exosomes
- (2017) Sander A. A. Kooijmans et al. Nature Biomedical Engineering
- Multistaged Nanovaccines Based on Porous Silicon@Acetalated Dextran@Cancer Cell Membrane for Cancer Immunotherapy
- (2016) Flavia Fontana et al. ADVANCED MATERIALS
- Cell source determines the immunological impact of biomimetic nanoparticles
- (2016) Michael Evangelopoulos et al. BIOMATERIALS
- Dendritic cell–derived exosomes for cancer therapy
- (2016) Jonathan M. Pitt et al. JOURNAL OF CLINICAL INVESTIGATION
- An integrated assessment of morphology, size, and complement activation of the PEGylated liposomal doxorubicin products Doxil®, Caelyx®, DOXOrubicin, and SinaDoxosome
- (2016) Peter P. Wibroe et al. JOURNAL OF CONTROLLED RELEASE
- Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
- (2016) Daniel Bobo et al. PHARMACEUTICAL RESEARCH
- Programmable polyproteams built using twin peptide superglues
- (2016) Gianluca Veggiani et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Adjuvant-Loaded Subcellular Vesicles Derived From Disrupted Cancer Cells for Cancer Vaccination
- (2016) Alexander S. Cheung et al. Small
- Recent Developments of Liposomes as Nanocarriers for Theranostic Applications
- (2016) Hang Xing et al. Theranostics
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Global Cancer Incidence and Mortality Rates and Trends--An Update
- (2015) L. A. Torre et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy
- (2015) Samuel G. Awuah et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Nivolumab in Previously Untreated Melanoma without BRAF Mutation
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab versus Ipilimumab in Advanced Melanoma
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adoptive cell transfer as personalized immunotherapy for human cancer
- (2015) S. A. Rosenberg et al. SCIENCE
- Nanoparticle-Based Manipulation of Antigen-Presenting Cells for Cancer Immunotherapy
- (2015) Ronnie H. Fang et al. Small
- Immune biomarkers of anti-EGFR monoclonal antibody therapy
- (2014) S. Trivedi et al. ANNALS OF ONCOLOGY
- Current concepts in the diagnosis and management of cytokine release syndrome
- (2014) D. W. Lee et al. BLOOD
- Metformin in Patients With Type 2 Diabetes and Kidney Disease
- (2014) Silvio E. Inzucchi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery
- (2014) Ronnie H. Fang et al. NANO LETTERS
- Doxorubicin Eliminates Myeloid-Derived Suppressor Cells and Enhances the Efficacy of Adoptive T-Cell Transfer in Breast Cancer
- (2013) D. Alizadeh et al. CANCER RESEARCH
- nab-Paclitaxel mechanisms of action and delivery
- (2013) Denise A. Yardley JOURNAL OF CONTROLLED RELEASE
- Immunogenic Cell Death in Cancer Therapy
- (2012) Guido Kroemer et al. Annual Review of Immunology
- Doxil® — The first FDA-approved nano-drug: Lessons learned
- (2012) Yechezkel (Chezy) Barenholz JOURNAL OF CONTROLLED RELEASE
- Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin
- (2012) B. Zakeri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chemotherapy-induced alopecia
- (2011) Susan Y. Chon et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Nanopharmacy: Inorganic nanoscale devices as vectors and active compounds
- (2010) Pilar Rivera Gil et al. PHARMACOLOGICAL RESEARCH
- Artificial exosomes as tools for basic and clinical immunology
- (2009) Hugo De La Peña et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Optimizing denileukin diftitox (Ontak®) therapy
- (2008) Madeleine Duvic et al. Future Oncology
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started